Overview of hInsight-NX's Stake Reduction#
hInsight-NX, LLC, a Nashville-based company, has announced a reduction in its voting rights in Ondine Biomedical Inc. from 8.15% to 7.53%. This change was disclosed in a press release on Monday.
Details of the Reduction#
The reduction in voting rights occurred on May 5, 2026, when hInsight-NX notified Ondine Biomedical of the change. The company currently holds 42,272,654 voting rights associated with its shares in Ondine, which is a non-UK issuer.
Nature of the Change#
It's important to note that this reduction was not due to buying or selling shares but rather a change in the breakdown of voting rights. hInsight-NX maintains its position directly, without using any financial instruments to hold its shares.
Control and Ownership#
The filing clarifies that hInsight-NX is not controlled by any individual or legal entity and does not have control over any other entities that hold interests in Ondine Biomedical. This transparency is crucial for investors and stakeholders in understanding the ownership structure.